FDA Adverse Event Injury Summary report: N

GYNECARE PROLIFT TOTAL PELVIC FLOOR REPAIR SYSTEM

MDR report key: 3222791 · Received July 12, 2013

Report

Report Number
2210968-2013-12972
Event Type
Injury
Date Received
July 12, 2013
Report Date
April 22, 2016
Manufacturer
ETHICON INC.
Product Code
OTP
PMA / PMN Number
K013718
Removal / Correction Number
NA
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
SC, US
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

(B)(4).

Additional Manufacturer Narrative · 1

(B)(4): NO CONCLUSION CAN BE DRAWN AT THIS TIME. SHOULD ADDITIONAL INFORMATION BE OBTAINED, A SUPPLEMENTAL 3500A FORM WILL BE SUBMITTED ACCORDINGLY.

Additional Manufacturer Narrative · 1

DATE SENT TO THE FDA: 02/10/2014. IT WAS REPORTED THAT THE PATIENT UNDERWENT A GYNECOLOGICAL PROCEDURE AND MESH WAS IMPLANTED ALONG WITH CONCURRENT TVH, BILATERAL UTEROSACRAL SUSPENSION, AND CYSTOSCOPY DUE TO STRESS URINARY INCONTINENCE AND STAGE 3 POP.

Additional Manufacturer Narrative · 1

(B)(4). IT WAS REPORTED THAT FOLLOWING INSERTION THE PATIENT EXPERIENCED OVERACTIVE BLADDER, INTRINSIC URETHRAL SPHINCTER DEFICIENCY, URINARY LEAKAGE, DIFFICULTY EMPTYING HER BLADDER, CONSTIPATION, URINARY INCONTINENCE, URINARY TRACT INFECTION,FREQUENCY, AND URGENCY.

Additional Manufacturer Narrative · 1

IT WAS REPORTED THAT THE PATIENT UNDERWENT MESH REVISION ON (B)(6) 2008 DUE TO PAIN AND SUI. (B)(4).

Description of Event or Problem · 1

IT WAS REPORTED THAT THE PATIENT UNDERWENT A GYNECOLOGICAL PROCEDURE ON (B)(6) 2006 AND MESH WAS IMPLANTED. THE PATIENT EXPERIENCED PAIN, EROSION OF HER INTERNAL BODILY TISSUE AND OTHER INJURIES FOLLOWING THE PROCEDURE. IT WAS REPORTED THAT THE PATIENT HAS UNDERGONE MULTIPLE SURGERIES AND REVISIONARY PROCEDURES. NO ADDITIONAL INFORMATION WAS PROVIDED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
322617 GYNECARE PROLIFT TOTAL PELVIC FLOOR REPAIR SYSTEM MESH, SURGICAL, SYNTHETIC, UROGYNECOLOGIC OTP ETHICON INC. UNK 1302688

Patients

Seq Age Sex Outcome Treatment
1 50 YR Required Intervention